The D-backs have agreed to terms with Brito for the second time this year, though there is still some paperwork that must be completed before the signing becomes official.
Brito was initially signed by the D-backs during Spring Training for $190,000, but Arizona voided his contract two weeks ago when he tested positive for metabolites of Stanozolol, a performance-enhancing substance.
"We reached an agreement with Socrates prior to any testing," assistant general manager Peter Woodfork said on the day the D-backs voided the contract. "When we were notified of his entry testing results, we immediately voided that agreement. The Diamondbacks obviously agree with Major League Baseball's strict drug policy. We will attempt to renegotiate new contract terms, but our first priority is to help the player understand the potential harm, policies and repercussions that surround such behavior."
Brito received a 50-game suspension for violating the Minor League Drug Prevention and Treatment Program and it will take effect when his deal with the D-backs becomes official.